Detection of immunoregulatory rheumatoid factor

Cover Page


Cite item

Full Text

Abstract

Regulatory rheumatoid factor (regRF) represents a separate rheumatoid factor population that might be potentially used for clinical diagnostics, whereas regRF-producing lymphocytes serve as a promising therapeutic target for autoimmune diseases. Hence, it is worth outlining conditions allowing to reliably detect regRF in humans and laboratory animals. The method of agglutination with tanned IgG-loaded red blood cells was used to measure level of regulatory rheumatoid factor, because it allows to identify solely regRF as compared to the latex fixation method detecting both the regulatory rheumatoid factor as well as the rheumatoid factor associated with rheumatic diseases. It was found that fresh or frozen serum should be used to detect regRF in rats. Freshly purified rat blood plasma stabilized with heparin, sodium citrate or EDTA did not allow to detect regRF, potentially being linked to the presence of fibrinogen known to demonstrate IgG binding activity. In addition, heparin itself also complicates regRF detection in rats. In humans, regRF was reliably detected in pre-frozen plasma stabilized with sodium citrate. Finally, false-negative results were obtained in a small number of cases while using blood serum for detecting regRF in humans.

About the authors

L. М. Beduleva

Udmurt State University

Author for correspondence.
Email: blv76@mail.ru

Beduleva Lyubov V. - PhD, MD (Biology), Head, Laboratory of Molecular and Cell Immunology

426034, Udmurt Republic, Izhevsk, Universitetskaya str., 1

Phone: 7 (3412) 91-64-26

Russian Federation

A. Yu. Sidorov

Udmurt State University

Email: fake@neicon.ru

Research Associate, Laboratory of Molecular and Cell Immunology

Izhevsk, Udmurt Republic

Russian Federation

N. N. Abisheva

Udmurt State University

Email: fake@neicon.ru

Research Associate, Laboratory of Molecular and Cell Immunology

Izhevsk, Udmurt Republic

Russian Federation

L. U. Gilmanova

Udmurt State University

Email: fake@neicon.ru

Junior Research Associate, Laboratory of Molecular and Cell Immunology

Izhevsk, Udmurt Republic

Russian Federation

A. N. Gorbushina

Udmurt State University

Email: fake@neicon.ru

Junior Research Associate, Laboratory of Molecular and Cell Immunology

Izhevsk, Udmurt Republic

Russian Federation

References

  1. Beduleva L., Menshikov I., Stolyarova E., Fomina K., Lobanova O., Ivanov P. Terentiev A. Rheumatoid factor in idiotypic regulation of autoimmunity. Int. J. Rheum. Dis., 2015, Vol. 18, pp. 408-420.
  2. Boehm T.K., DeNardin E. Fibrinogen binds IgG antibody and enhances IgG-mediated phagocytosis. Hum. Antibodies, 2008, Vol. 17, no. 3-4, pp. 45-56.
  3. Fong S., Chen P.P., Crowley J.J., Silverman G.J., Carson D.A. Idiotypes and the structural diversity of human rheumatoid factors. Springer Semin. Immunopathol., 1988, Vol. 10, pp. 189-201.
  4. Mageed R.A., Moyes S.P., Thompson K.M., Natvig J.B. Molecular and сellular aspects of human rheumatoid factor production and idiotypes. In: Shoenfeld Y., Kennedy R.C., Ferrone S. (ed) Idiotypes in Medicine: Autoimmunity, Infection and Cancer. Elsevier, 1997, pp. 135-155.
  5. Monestier M., Bellon B., Manheimer A.J., Bona C.A. Rheumatoid factors. Immunochemical, molecular, and regulatory properties. Ann. N. Y. Acad. Sci., 1986, Vol. 475, pp. 106-113.
  6. Sidorov A., Beduleva L., Menshikov I., Terentiev A., Stolyarova E., Abisheva N. Fc fragments of immunoglobulin G are an inductor of regulatory rheumatoid factor and a promising therapeutic agent for rheumatic diseases. Int. J. Biol. Macromol., 2017, Vol. 95, pp. 938-945.
  7. Sidorov A., Beduleva L., Menshikov I., Terentiev A., Cherepanov I. Physicochemical characteristics of human IgG Fc fragments that expose regulatory rheumatoid factor neoepitopes and may show promise as antirheumatic agents. Biotechnol. Appl. Biochem., 2019, Vol. 67, no. 2, pp. 287-293.
  8. Stolyarova E., Beduleva L., Menshikov I., Snigiryev A., Khramova T. Mechanism by which regulatory rheumatoid factor prevents experimental autoimmune encephalomyelitis. Endocr. Metab. Immune Disord. Drug Targets, 2018, Vol. 18, pp. 596-601.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2020 Beduleva L.М., Sidorov A.Y., Abisheva N.N., Gilmanova L.U., Gorbushina A.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № 77 - 11525 от 04.01.2002.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies